These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 8550831)

  • 21. Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats.
    Yu Y; Wang X; Liu C; Yao D; Hu M; Li J; Hu N; Liu L; Liu X
    Toxicol Appl Pharmacol; 2013 Feb; 266(3):375-84. PubMed ID: 23200776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells.
    Fehmann HC; Habener JF
    Endocrinology; 1992 Jan; 130(1):159-66. PubMed ID: 1309325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
    Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
    Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG; Pittner R; Jodka C; Smith P; Young A
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas.
    Göke R; Wagner B; Fehmann HC; Göke B
    Res Exp Med (Berl); 1993; 193(2):97-103. PubMed ID: 8516568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
    Flamez D; Van Breusegem A; Scrocchi LA; Quartier E; Pipeleers D; Drucker DJ; Schuit F
    Diabetes; 1998 Apr; 47(4):646-52. PubMed ID: 9568699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise training in Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus: effects on the B-cell mass, insulin content and fibrosis in the pancreas.
    Shima K; Zhu M; Noma Y; Mizuno A; Murakami T; Sano T; Kuwajima M
    Diabetes Res Clin Pract; 1997 Feb; 35(1):11-9. PubMed ID: 9113470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biophysical and pharmacological properties of glucagon-like peptide-1 in rats under isoflurane anesthesia.
    Kawano T; Tanaka K; Chi H; Eguchi S; Yamazaki F; Kitamura S; Kumagai N; Yokoyama M
    Anesth Analg; 2012 Jul; 115(1):62-9. PubMed ID: 22504208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass.
    Leahy JL; Bonner-Weir S; Weir GC
    Diabetes; 1984 Jul; 33(7):667-73. PubMed ID: 6203798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.
    Perfetti R; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2000 Dec; 141(12):4600-5. PubMed ID: 11108273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation.
    Bollheimer LC; Skelly RH; Chester MW; McGarry JD; Rhodes CJ
    J Clin Invest; 1998 Mar; 101(5):1094-101. PubMed ID: 9486980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomy.
    Zangen DH; Bonner-Weir S; Lee CH; Latimer JB; Miller CP; Habener JF; Weir GC
    Diabetes; 1997 Feb; 46(2):258-64. PubMed ID: 9000703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
    Heller RS; Aponte GW
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
    Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
    J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of beta cell mass: partial insulin secretory compensation from the residual beta cell population in the nicotinamide-streptozotocin Göttingen minipig after oral glucose in vivo and in the perfused pancreas.
    Larsen MO; Rolin B; Gotfredsen CF; Carr RD; Holst JJ
    Diabetologia; 2004 Nov; 47(11):1873-8. PubMed ID: 15565374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets.
    Kim S; Wan Kim S; Bae YH
    Biomaterials; 2005 Jun; 26(17):3597-606. PubMed ID: 15621250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.
    Xu G; Stoffers DA; Habener JF; Bonner-Weir S
    Diabetes; 1999 Dec; 48(12):2270-6. PubMed ID: 10580413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.